Luca Monzo
@LucaMonzo
Followers
70
Following
114
Media
4
Statuses
55
🇮🇹🇫🇷 | Heart Failure Specialist @CHRU_de_Nancy | Researcher @CiCPNancy | Assistant Professor @Univ_Lorraine | #FESC
Nancy
Joined January 2014
RT @GuiBaudry: 🌍 Excited to share our publication led by @hvanspall exploring the consistency of HFrEF treatments in underrepresented grou….
0
12
0
RT @CiCPNancy: Association of ventricular–arterial coupling with biomarkers involved in heart failure pathophysiology – the STANISLAS cohor….
0
4
0
RT @CiCPNancy: Decoding proteins in cardiometabolic disease: the power and challenges of proteomics @NicolasGirerd @LucaMonzo @Heart_BMJ….
0
2
0
Increased β-OHB seems to reflect the heightened lipolytic state induced by neurohormonal overdrive in advanced HFrEF, and not a rescue mechanism to improve energetics as previously proposed. @CiCPNancy @EJHFEiC @ESC_Journals @Univ_Lorraine @MayoClinic
0
1
3
RT @CiCPNancy: Hypothermia in patients with cardiac arrest prior to ECMO-VA: Insight from the HYPO-ECMO trial - @NicolasGirerd @GuiBaudry @….
0
2
0
RT @HFA_President: 🧡🧡 #HeartFailureAwarenessDays 2024 🧡🧡. It's happening now, from 29 April to 5 May. It is our duty to advocate for early….
0
27
0
RT @CiCPNancy: Use of the Win Ratio Analysis in Critical Care Trials.@LucaMonzo @GuiBaudry @NicolasGirerd @INICRCT @CHRU_de_Nancy @atscommu….
0
2
0
RT @CiCPNancy: Pressure overload is associated with right ventricular dyssynchrony in heart failure with reduced ejection fraction @LucaMon….
0
1
0
RT @CiCPNancy: Tackling the ReD(S) Flag of Congestion in Heart Failure.@NicolasGirerd @LucaMonzo @INICRCT @Univ_Lorraine |#Cardiology #Card….
0
2
0
RT @CiCPNancy: Use of the Win Ratio Analysis in Critical Care Trials.@LucaMonzo @GuiBaudry @NicolasGirerd @ATSBlueE….
0
1
0
New in @ESC_Journals our research on RV dyssynchrony (RVD) in advanced HFrEF:. - Main determinant of RVD is RVEF .- Strong link between RVD and increased clinical risk.- Sildenafil acutely improves RVD reducing afterload. @CiCPNancy @ikemcz.
0
2
5
New insights from COMMANDER-HF trial: Plasma D-dimer best predictive tool for stroke risk among HFrEF patients with sinus rhythm and recent HF hospitalization. Low-dose rivaroxaban lowers risk in high d-dimer group @NicolasGirerd @CiCPNancy @FaiezZANNAD.
0
2
4
Best lessons learned at @CVCTForum keynote lecture by Milton Packer @GuiBaudry @_antocannata @GianluSava @WilfriedMullens @NicolasGirerd
0
1
7
RT @NicolasGirerd: Happy that the REMI study was finally published in EJHF ! Bravo to @LucaMonzo for this achievement. Let’s hear him give….
0
2
0
RT @CiCPNancy: Dr. @LucaMonzo, cardiologist at CIC-P in Nancy, discuss about the REMI study. Aldosterone after MI associated with adverse L….
0
6
0
RT @WilfriedMullens: Top-notch science, interactivity, scientific collaboration, mentorship, live long friendship and so much more. .
0
8
0
69% di borse di specializzazione MEU non assegnate #SSM23. I politici continuino a guardare il dito (numero chiuso) e non la luna (stipendi, protezione dalle aggressioni, sistema panpenalistico). @VincenzoDeLuca @GiorgiaMeloni .
0
0
3
RT @GuiBaudry: Do you know the ESC guidelines on advanced heart failure well? .Take 10 min to answer the HFA/ESC survey. .
0
6
0
RT @mmamas1973: Any junior doctor / medical student that leads a project in my group/ writes it = first author. Any junior doctor that cont….
0
92
0